Exelixis
EXEL
#1545
Rank
$14.75 B
Marketcap
$59.53
Share price
1.71%
Change (1 day)
60.11%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company